Year archive

MESOBLAST LTD — 2021 filings

All 101 regulatory filings released by MESOBLAST LTD (MESO) in 2021, sourced directly from the official regulator.

101 Filings

2021 Period

2021 filings (101)

Filing	Released	Lang
Update on FDA Meeting for Remestemcel-L in Paediatric GvHD 3 pages 186.5KB Regulatory Filings	2021-12-30	English
REGISTRATION STATEMENT Registration Form	2021-12-23	English
6-K Foreign Filer Report	2021-12-17	English
FDAs OTAT Agrees to Primary Endpoint for Back Pain 3 pages 168.7KB Regulatory Filings	2021-12-15	English
6-K Foreign Filer Report	2021-12-14	English
Pause in Trading 1 page 111.4KB Regulatory Filings	2021-12-13	English
Update on Novartis Agreement 2 pages 136.9KB Regulatory Filings	2021-12-13	English
6-K Foreign Filer Report	2021-12-07	English
Global CardioVascular Clinical Trialists Forum Presentation 17 pages 1.7MB Regulatory Filings	2021-12-05	English
Rexlemestrocel Greatest Benefit in Diabetics and Ischemics 3 pages 236.0KB Regulatory Filings	2021-12-05	English
6-K Foreign Filer Report	2021-12-02	English
Mesoblast Chairman Message to 2021 AGM 3 pages 216.4KB Regulatory Filings	2021-11-28	English
CEO Presentation to 2021 Annual General Meeting 33 pages 3.9MB Regulatory Filings	2021-11-28	English
Results of Meeting 2 pages 159.2KB Regulatory Filings	2021-11-28	English
6-K Foreign Filer Report	2021-11-25	English
6-K Foreign Filer Report	2021-11-24	English
First Quarter Financial Results on Form 6-K 85 pages 542.7KB Regulatory Filings	2021-11-23	English
First Quarter Results Presentation 36 pages 3.6MB Regulatory Filings	2021-11-23	English
MSB Q1 Financial Results and Operational Highlights 9 pages 579.1KB Regulatory Filings	2021-11-23	English
Mesoblast Q1 Financial Results Webcast 1 page 129.2 Regulatory Filings	2021-11-22	English
Proposed issue of securities - MSB 6 pages 29.7KB Regulatory Filings	2021-11-21	English
MSB and Oaktree Conclude Refinancing of Senior Debt Facility 2 pages 141.9KB Regulatory Filings	2021-11-21	English
6-K Foreign Filer Report	2021-11-16	English
AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes 3 pages 213.9KB Regulatory Filings	2021-11-14	English
6-K Foreign Filer Report	2021-11-09	English
6-K Foreign Filer Report	2021-11-04	English
Appendix 4C Quarterly Activity Report 10 pages 356.5KB Regulatory Filings	2021-10-28	English
Appendix 4G and Corporate Governance Statement 22 pages 362.6KB Regulatory Filings	2021-10-28	English
Notice of Annual General Meeting and Proxy Form 30 pages 1.9MB Regulatory Filings	2021-10-28	English
Annual Report to Shareholders 228 pages 4.1MB Regulatory Filings	2021-10-28	English
6-K Foreign Filer Report	2021-10-19	English
Remestemcel-L Improves Survival in High-Risk Acute GvHD 3 pages 198.9KB Regulatory Filings	2021-10-17	English
Notification regarding unquoted securities - MSB 6 pages 27.4KB Regulatory Filings	2021-10-13	English
Notification of cessation of securities - MSB 4 pages 24.3KB Regulatory Filings	2021-10-13	English
6-K Foreign Filer Report	2021-10-08	English
CHF Late Breaker Presentation at American Heart Association 2 pages 168.4KB Regulatory Filings	2021-10-06	English
6-K Foreign Filer Report	2021-09-01	English
20-F Annual Report FY 2021	2021-08-31	English
Preliminary Final Report including Appendix 4E 227 pages 2.9MB Regulatory Filings	2021-08-30	English
Annual Financial Results Presentation 34 pages 3.4MB Regulatory Filings	2021-08-30	English
MSB Annual Financial Results and Operational Progress 10 pages 649.9KB Regulatory Filings	2021-08-30	English
Mesoblast 2021 Full Year Financial Results Webcast 1 Regulatory Filings	2021-08-29	English
Appendix 3G and 3H 22 pages 435.2KB Regulatory Filings	2021-08-29	English
6-K Foreign Filer Report	2021-08-13	English
Mesoblast Management Update 2 pages 137.9KB Regulatory Filings	2021-08-09	English
6-K Foreign Filer Report	2021-08-03	English
Appendix 4C Quarterly Activity Report 11 pages 360.3KB Regulatory Filings	2021-07-29	English
Release of Shares from Voluntary Escrow 1 page 105. Regulatory Filings	2021-07-28	English
6-K Foreign Filer Report	2021-07-21	English
COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT 3 pages 185.8KB Regulatory Filings	2021-07-18	English
COVID ARDS Trial Results Presentation 27 pages 3.0MB Regulatory Filings	2021-07-15	English
COVID ARDS Trial Respiratory Outcomes Presented 2 pages 175.4KB Regulatory Filings	2021-07-15	English
Appendix 3Y - Change of Director's Interest Notice 3 pages 287.8KB Regulatory Filings	2021-07-13	English
6-K Foreign Filer Report	2021-07-09	English
Appendix 3G 18 pages 396.5KB Regulatory Filings	2021-07-06	English
6-K Foreign Filer Report	2021-07-02	English
Mesoblast Update on Chronic Low Back Pain Program 3 pages 189.6KB Regulatory Filings	2021-06-30	English
6-K Foreign Filer Report	2021-06-04	English
6-K Foreign Filer Report	2021-06-04	English
Mesoblast Q3 Financial Results Webcast 1 page 132.7 Regulatory Filings	2021-06-02	English
Third Quarter Financial Results on Form 6-K 106 pages 653.0KB Regulatory Filings	2021-06-02	English
Third Quarter Results Presentation 40 pages 2.0MB Regulatory Filings	2021-06-02	English
MSB Reports Q3 Financial Results and Operational Highlight 9 pages 493.5KB Regulatory Filings	2021-06-02	English
6-K Foreign Filer Report	2021-05-27	English
Remestemcel-L for COPD Published in Respiratory Research 2 pages 173.3KB Regulatory Filings	2021-05-24	English
6-K Foreign Filer Report	2021-05-03	English
Mesoblast Corporate Update Webcast 2 pages 157.2KB Regulatory Filings	2021-04-29	English
Appendix 4C Quarterly Activity Report 12 pages 380.4KB Regulatory Filings	2021-04-29	English
COVID ARDS Trial Topline 60-Day Results 3 pages 199.2KB Regulatory Filings	2021-04-29	English
6-K Foreign Filer Report	2021-04-08	English
REGISTRATION STATEMENT Regulatory Filings	2021-04-07	English
Director's Interest Notice - Appendix 3X 2 pages 227.7KB Regulatory Filings	2021-04-05	English
6-K Foreign Filer Report	2021-04-01	English
Mesoblast Operational Highlights and Upcoming Milestones 3 pages 205.3KB Regulatory Filings	2021-03-30	English
6-K Foreign Filer Report	2021-03-30	English
Director Appointment/Resignation 2 pages 178.7KB Regulatory Filings	2021-03-28	English
AUTOMATIC SHELF REGISTRATION STATEMENT Regulatory Filings	2021-03-23	English
Prospectus for Warrants in Connection with US$110M Raise 42 pages 574.8KB Regulatory Filings	2021-03-14	English
6-K Foreign Filer Report	2021-03-11	English
Cleansing Notice and Appendix 2A 16 pages 450.9KB Regulatory Filings	2021-03-08	English
MSB Closes US$110M Raise Led By US Strategic Investor Group 2 pages 197.5KB Regulatory Filings	2021-03-08	English
6-K Foreign Filer Report	2021-03-05	English
6-K Foreign Filer Report	2021-03-03	English
Cleansing Notice and Appendix 2A 16 pages 427.2KB Regulatory Filings	2021-03-02	English
6-K Foreign Filer Report	2021-03-02	English
Mesoblast Raises US$110M Led By US Strategic Investor Group 3 pages 203.5KB Regulatory Filings	2021-03-01	English
Proposed issue of Securities - MSB 6 pages 31.0KB Regulatory Filings	2021-03-01	English
Trading Halt 2 pages 213.3KB Regulatory Filings	2021-02-25	English
Half Year Report and Accounts (including Appendix 4D) 115 pages 842.0KB Regulatory Filings	2021-02-25	English
6-K Foreign Filer Report	2021-02-19	English
Remestemcel-L for COVID-19 MIS-C published in Pediatrics 3 pages 200.3KB Regulatory Filings	2021-02-16	English
6-K Foreign Filer Report	2021-02-11	English
Mesoblast Corporate Update Webcast 2 pages 184.8KB Regulatory Filings	2021-02-10	English
Mesoblast Phase 3 Chronic Low Back Pain Results 6 pages 372.6KB Regulatory Filings	2021-02-10	English
MESOBLAST LIMITED Major Shareholding Notification	2021-02-03	English
6-K Foreign Filer Report	2021-02-01	English
Appendix 4C Quarterly Activity Report 13 pages 216.5KB Regulatory Filings	2021-01-28	English
6-K Foreign Filer Report	2021-01-19	English
Mesoblast Healthcare Conference Investor Presentation 35 pages 1.7MB Regulatory Filings	2021-01-11	English
CHF Phase 3 Trial Results Presented at Investor Conference 3 pages 126.0KB Regulatory Filings	2021-01-11	English
Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF 3 pages 132.5KB Regulatory Filings	2021-01-10	English

Filings by year

2026 64 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings